Abstract
The transcriptional activity of the human androgen receptor (hAR), like other nuclear receptors, is dependent on accessory factors. One such factor is c-Jun, which has been shown to have a selective function of mediating androgen receptor-dependent transactivation. This c-Jun activity is inhibited by c-Fos, another protooncoprotein that can dimerize with c-Jun to form the transcription factor AP-1. Here we show that c-Jun mediates hAR-induced transactivation from the promoter of the androgen-regulated gene, human kallikrein-2 (hKLK2), and c-Fos blocks this activity. Using c-Fos truncation mutants and measuring hKLK2-dependent transcription, we have determined that the bZIP region of c-Fos is required and sufficient for inhibiting c-Jun enhancement of hAR transactivation. Further truncation analysis of the bZIP shows that the c-Fos dimerization function, mediated through the leucine zipper, is essential for the negative activity, whereas DNA binding, mediated through the basic region, is dispensable. These results suggest that heterodimerization by c-Fos with c-Jun blocks c-Jun’s ability to enhance hAR-induced transactivation.
Similar content being viewed by others
References
Mangelsdorf, D., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. (1995). Cell 83, 835–839.
Mangelsdorf, D. J. and Evans, R. M. (1995). Cell 83, 841–850.
Beato, M., Herrlich, P., and Schutz, G. (1995). Cell 83, 851–857.
Kastner, P., Mark, M., and Chambon, P. (1995). Cell 83, 859–869.
Thummel, C. (1995). Cell 83, 571–877.
Evans, R. M. (1988). Science 240, 889–895.
Gronemeyer, H. (1992). FASEB J. 6, 2524–2529.
Chang, C., Kokontis, J., and Liao, S. (1988). Science 240, 324–326.
Gill, G. and Tjian, R. (1992). Curr. Biol. 2, 236–242.
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., and Gronemeyer, H. (1996). EMBO J. 15, 3667–75.
Onate, S. A., Tsai, S. Y., Tsai, M. J., and O’Malley, B. W. (1995). Science 270, 1354–1357.
Kamei, Y., Xu, L, Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., et al. (1996). Cell 85, 403–414.
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Kakajima, T., Schulman, I. G., Juguilon, H., et al. (1996). Nature 383, 99–103.
Yeh, S. and Chang, C. (1996). Proc. Natl. Acad. Sci. USA 93, 5517–5521.
Angel, P. and Karin, M. (1991). Biochim. Biophys. Acta 1072, 129–157.
Jonat, C., Rahmsdorf, H. J., Park, K-K., Cato, A. C. B., Gebel, S., Ponta, H., et al. (1990). Cell 62, 1189–1204.
Lucibello, F., Slater, E. P., Jooss, K., Beato, M., and Muller, R. (1990). EMBO J. 9, 2827–2834.
Schule, R., Rangarajan, P., Kleiwer, S., Ransone, L. J., Bolado, J., Yang, N., et al. (1990). Cell 62, 1217–1226.
Yang-Yen, H-F., Zhang, X-K., Graupner, G., Tzuckerman, M., Sakamoto, B., Karin, M., et al. (1991). New Biol. 3, 1206–1219.
Shemshedini, L., Knauthe, R., Sassone-Corsi, P., Pornon, A., and Gronemeyer, H. (1992). EMBO J. 10, 3839–3849.
Bubulya, A., Wise, S. C., Shen, X-Q., Burmeister, L. A., and Shemshedini, L. (1996). J. Biol. Chem. 271, 24,583–24,589.
Maroder, M., Farina, A. R., Vacca, A., Felli, M. P., Meco, D., Screpanti, I., et al. (1993). Mol. Endocr. 7, 570–584.
Karin, M. (1995). J. Biol. Chem. 270, 16,483–16,486.
Derijard, B., Hibi, M., Wu, I-H., Barrtee, T., Su, B., Deng, T., et al. (1994). Cell 76, 1–20.
Devary, Y., Gottlieb, R., Smeal, T., Bauskin, A., Ben-Neriah, Y., and Karin, M. (1992). Cell 71, 1081–1091.
Deng, T. and Karin, M. (1994). Nature 371, 171–175.
Wise, S. C., Burmeister, L. A., Zhou, X.-F., Bubulya, A., Oberfield, J. L., Birrer, M. J., et al. (1998). Oncogene 16, 2001–2209.
Murtha, P., Tindall, D., and Young, C. (1993). Biochemistry 32, 6459–6464.
Green, S., Isseman, I., and Sheer, E. (1988). Nucleic Acids Res. 16, 369.
Fearon, E. R., Finkel, T., Gillison, M. L., Kennedy, S. P., Casella, J. F., Tomaselli, G. F., et al. (1992). Proc. Natl. Acad. Sci. USA 89, 7958–7962.
Langley, E., Zhou, Z., and Wilson, E. M. (1995). J. Biol. Chem. 270, 29,983–29,990.
Neuberg, M., Schuermann, M., and Muller, R. (1991). Oncogene 6, 1325–1333.
Pfahl, M. (1993). Endocr. Rev. 14, 651–658.
Ransone, L. J., Kerr, L. D., Schmitt, M. J., Wamsley, P., and Verma, I. M. (1993). Gene Exp. 3, 37–48.
Martin, M. L., Lieberman, P. M., and Curran, T. (1996). Mol. Cell. Biol. 16, 2110–2118.
Gentz, R., Rauscher, F. J. III, Abate, C., and Curran, T. (1989). Science 243, 1695–1699.
Abate, C., Luk, D., Gentz, R., Rauscher, F. J. III, and Curran, T. (1990). Proc. Natl. Acad. Sci. USA 87, 1032–1036.
Cohen, D. and Curran, T. (1990). Oncogene, 929–939.
Aarnisalo, P., Palvimo, J. J., and Janne, O. A. (1998). Proc. Natl. Acad. Sci. USA 95, 2122–2127.
Lee, J. S., See, R. H., Deng, T., and Shi, Y. (1996). Mol. Cell. Biol. 16, 4312–4326.
Bannister, A. J. and Kouzarides, T. (1995). EMBO J. 14, 4758–4762.
Gronemeyer, H., Turcotte, B., Quirin-Stricker, C., Bocquel, M., Meyer, M., Krozowski, Z., et al. (1987). EMBO J. 6, 3985–3994.
Finkel, T., Duc, J., Fearon, E., Dang, C., and Tomaselli, G. F. (1993). J. Biol. Chem. 268, 5–8.
Dang, C., Barrett, J., Villa-Garcia, M., Resar, L., Kato, G., and Fearon, E. (1991). Mol. Cell. Biol. 11, 954–962.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tillman, K., Oberfield, J.L., Shen, XQ. et al. c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation. Endocr 9, 193–200 (1998). https://doi.org/10.1385/ENDO:9:2:193
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:9:2:193